Abstract | PURPOSE: To present an unusual case in which the honeycomb opacities of Thiel-Behnke corneal dystrophy disappeared during a course of chronic Thygeson superficial punctate keratitis. CASE: A 29-year-old woman with a 5-year history of decreased visual acuity in both eyes had bilateral honeycomb-shaped corneal opacities, located mainly in the superficial central cornea. She was diagnosed as having Thiel-Behnke corneal dystrophy, which we confirmed genetically. During follow-up, her left eye was affected by chronic Thygeson superficial punctate keratitis, and the honeycomb opacity in this eye was noted to have disappeared. CONCLUSIONS: We observed the dissolution of honeycomb-like corneal opacities in a patient with confirmed Thiel-Behnke corneal dystrophy after the patient subsequently contracted chronic Thygeson superficial punctate keratitis. We surmise that epithelial inflammation associated with Thygeson epithelial keratitis may play a role in dissolving the honeycomb opacities.
|
Authors | Akira Kobayashi, Shigeyuki Ijiri, Taeko Ohta, Kazuhisa Sugiyama |
Journal | Cornea
(Cornea)
Vol. 24
Issue 8
Pg. 1029-30
(Nov 2005)
ISSN: 0277-3740 [Print] United States |
PMID | 16227859
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Glucocorticoids
- Ophthalmic Solutions
- Hyaluronic Acid
- Fluorometholone
|
Topics |
- Adjuvants, Immunologic
(administration & dosage, therapeutic use)
- Adult
- Cornea
(pathology)
- Corneal Dystrophies, Hereditary
(complications, pathology)
- Corneal Opacity
(etiology, pathology)
- Drug Therapy, Combination
- Female
- Fluorometholone
(administration & dosage, therapeutic use)
- Follow-Up Studies
- Glucocorticoids
(administration & dosage, therapeutic use)
- Humans
- Hyaluronic Acid
(administration & dosage, therapeutic use)
- Keratitis
(complications, drug therapy, pathology)
- Ophthalmic Solutions
- Remission, Spontaneous
|